Description
What it is
GLP-1 receptor agonist.
Mechanism
Semaglutide activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying and promote satiety.
Specifications
- Peptide content: 20mg / vial
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
For laboratory research only. Not for human or veterinary use.
